Intravenous mannitol does not increase blood-brain barrier permeability to inert dyes in the adult rat forebrain

NeuroReport

Volumn 24, Issue 6, 2013, Pages 303-307

  Chen, Kuen Bao ^a,b   Wei, Vivi Chiali ^a   Yen, Lola Fenghuei ^a   Poon, Kin Shing ^a,b   Liu, Yu Cheng ^a,b   Cheng, Ka Shun ^a,b   Chang, Chia Sheng ^a,b   Lai, Ted Weita ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

blood brain barrier; Evans blue dye; mannitol; route of administration; sodium fluorescein dye

Indexed keywords

EVANS BLUE; MANNITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TISSUE; CIRCULATION; CONTROLLED STUDY; CORPUS STRIATUM; EXTRAVASATION; FOREBRAIN; HIPPOCAMPUS; MALE; MOTOR CORTEX; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY;

ANIMALS; BLOOD PROTEINS; BLOOD-BRAIN BARRIER; BRAIN; CAROTID ARTERY, INTERNAL; COLORING AGENTS; EVANS BLUE; FLUORESCEIN; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; MANNITOL; PERMEABILITY; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84875859038     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32835f8acb     Document Type: Article

References (16)

1. Rangel-Castilla L, Gopinath S, Robertson CS. Management of intracranial hypertension. Neurol Clin 2008; 26:521-541, x. (Pubitemid 351734581)
2. Ghajar J, Hariri RJ, Narayan RK, Iacono LA, Firlik K, Patterson RH. Survey of critical care management of comatose, head-injured patients in the United States. Crit Care Med 1995; 23:560-567.
3. Wakai A, Roberts I, Schierhout G. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2007; CD001049.
4. Ropper AH. Hyperosmolar therapy for raised intracranial pressure. N Engl J Med 2012; 367:746-752.
5. Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992; 77:584-589.
6. Doolittle ND, Miner ME, Hall WA, Siegal T, Jerome E, Osztie E, et al. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 2000; 88: 637-647. (Pubitemid 30056941)
7. Rapoport SI. Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy. Expert Opin Investig Drugs 2001; 10: 1809-1818. (Pubitemid 32982807)
8. Angelov L, Doolittle ND, Kraemer DF, Siegal T, Barnett GH, Peereboom DM, et al. Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. J Clin Oncol 2009; 27:3503-3509.
9. Rapoport SI, Hori M, Klatzo I. Reversible osmotic opening of the blood-brain barrier. Science 1971; 173:1026-1028.
10. Chen KB, Kuo EY, Poon KS, Cheng KS, Chang CS, Liu YC, et al. Increase in Evans blue dye extravasation into the brain in the late developmental stage. Neuroreport 2012; 23:699-701.
11. Rapoport SI, Thompson HK. Osmotic opening of the blood-brain barrier in the monkey without associated neurological deficits. Science 1973; 180:971.
12. McCarty DM, DiRosario J, Gulaid K, Muenzer J, Fu H. Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice. Gene Ther 2009; 16:1340-1352.
13. Fu H, Muenzer J, Samulski RJ, Breese G, Sifford J, Zeng X, et al. Selfcomplementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol Ther 2003; 8:911-917. (Pubitemid 38072303)
14. Yasuhara T, Hara K, Maki M, Xu L, Yu G, Ali MM, et al. Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts. J Cell Mol Med 2010; 14:914-921.
15. Borlongan CV, Hadman M, Sanberg CD, Sanberg PR. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004; 35:2385-2389. (Pubitemid 39311268)
16. Borlongan CV, Glover LE, Sanberg PR, Hess DC. Permeating the blood-brain barrier and abrogating the inflammation in stroke: implications for stroke therapy. Curr Pharm Des 2012; 18:3670-3676.